2

Saturday May 25, 2024 from 16:00 to 17:30

Room: Regency

> Poster POS-62 Histotype distribution shift of ovarian cancers following opportunistic salpingectomy

Ramlogan Sowamber

BC Cancer

Abstract

Histotype distribution shift of ovarian cancers following opportunistic salpingectomy

Ramlogan Sowamber1,2,5, Alex Lukey1,2,6, Dawn Cochrane1,2, Blake Gilks1,2,4, Gillian Hanley1,2,3,6, David G. Huntsman1,2,4,5.

1Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada; 2Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada; 3BC Children’s Hospital, Vancouver, BC, Canada; 4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; 5Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; 6Department of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

Introduction – Opportunistic salpingectomy (OS) is a procedure that involves the removal of the fallopian tubes at the time of other surgeries for the prevention of ovarian cancers. Ovarian cancer consists of distinct histotypes including: High Grade Serous Carcinoma (HGSC), Clear Cell Ovarian Carcinoma (CCOC), endometrioid carcinoma, mucinous carcinoma and Low Grade Serous Carcinoma (LGSC). The origin of the most lethal histotype, HGSC, is the fallopian tube. OS aims to prevent ovarian cancer by removing the origin of these cancers. We hypothesize that post-OS, a histotype distribution shift will show a reduction in the overall numbers of ovarian cancers, including HGSC. We aim to show that tumors arising post-OS are molecularly distinct from tumors arising in patients with fallopian tubes in-tact.

Methods: We will use a case-based and population-based approached to identify tumors that arise following OS. Cox-proportional hazard analysis will be used to determine the histotype distribution shift following OS. We will qualitatively analyze tumors using low-pass whole genome sequencing, targeted sequencing and immunohistochemistry. We aim to acquire 150 carcinomas and 300 controls to perform targeted sequencing on 275 cancer genes (6M reads).

Results - We collaborated with institutions from across Canada, the U.S.A, the Netherlands and the United Kingdom. Our preliminary cohort consists of 19 cases with  26.3% HGSC cases (n=5), 26.3% are endometrioid carcinoma (n=5), 21.1% (n=4) are CCOC, 10.5% are LGSC (n=2), and three cases are mucinous carcinoma (15.8%). One case had a precursor lesion and the tumor had a TP53 frameshift mutation (c229fs) with null p53 staining.

Conclusion – Our preliminary data indicates a histotype distribution shift following opportunistic salpingectomy. HGSCs are reduced relative to historical numbers of ovarian cancers from patients with fallopian tubes in-tact. We welcome others to join this collaborative effort.

Department of Defense Ovarian Cancer Research Program. BC Cancer Research. Canadian Institutes of Health Research.

Presentations by Ramlogan Sowamber

© 2024 CCOCR 2024